Healthtech Startups

Antidote Health offers individual and family ACA health insurance plans with $0 primary care visits and unlimited virtual care, plus on-demand telehealth via subscription or one-time visits. Its plans are available to consumers in Arizona and Ohio, with services managed through a single app.

4 investors

Antios Therapeutics develops antiviral therapies for hepatitis B virus (HBV) and other viral diseases, including its Active Site Polymerase Inhibitor Nucleotide (ASPIN) ATI-2173 and a capsid assembly modulator program. Its treatments aim to suppress HBV replication and work toward a functional cure for HBV-infected patients.

4 investors

Apella provides an ambient AI platform that connects to the EHR to give hospital surgical teams real-time operating room intelligence, case duration forecasts, and automated documentation. It is used by health systems and perioperative staff to reduce delays, optimize OR scheduling and block utilization, and track surgical performance.

4 investors

Apero is a healthcare software platform that provides scheduling, visit notes, revenue cycle management, patient billing, prescriptions, and financial reporting for medical practices. The product serves practices of all sizes and emphasizes fast implementation and reduced administrative burden.

4 investors

Avvio Medical develops Microbubble SonoLithotripsy, a minimally invasive outpatient procedure that uses low-intensity ultrasound to break down ureteral stones without requiring general anesthesia or stents. The technology is designed for clinical-stage development and aims to reduce treatment wait times and expand access to stone care in various clinical settings.

4 investors

Applied Cognition develops neuroscience-based therapeutics and diagnostics, leveraging AI and deep expertise in drug development and clinical research for neurological disorders. The company combines scientific discovery with translational research and commercialization capabilities.

4 investors

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function. The company targets patients with severe emphysema who have limited treatment options.

4 investors

Aqtual is a precision medicine company led by experienced healthcare professionals, entrepreneurs, and technical experts.

4 investors

4 investors

Arini is an AI-powered front desk system for dental groups, DSOs, and private practices that handles patient calls and text messages 24/7, offering scheduling, call routing, and custom workflow management. The platform integrates with existing practice management software and phone systems to book appointments and reduce missed calls.

4 investors

Arogga is an online pharmacy in Bangladesh selling prescription and OTC medicines, healthcare devices, beauty, baby care, and wellness products, with prescription verification by licensed pharmacists and nationwide home delivery. It also offers home lab-test sample collection and online doctor consultations for consumers across all 64 districts of Bangladesh.</parameter> <parameter name="founders">[]

4 investors

ARS Pharma develops needle-free epinephrine treatments, including neffy, an FDA-approved epinephrine nasal spray for patients and caregivers managing allergic reactions. The company focuses on providing portable, easy-to-use alternatives to needle-based epinephrine delivery.

4 investors

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs. The platform aggregates medical, pharmaceutical, and claims data to help benefits teams make decisions that improve outcomes and lower spending.

4 investors

Artiva Biotherapeutics is a clinical-stage biotechnology company developing natural killer (NK) cell-based therapies for patients with autoimmune diseases. Its lead candidate, AlloNK, is a non-genetically modified, cryopreserved NK cell therapy being evaluated in clinical trials in combination with B-cell targeted monoclonal antibodies for conditions such as rheumatoid arthritis and Sjögren's disease.

4 investors

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals. Its Swiss portfolio includes the antiepileptic medication Ontozry (cenobamate).

4 investors

Asha Health provides AI-powered software that automates clinical workflows and administrative tasks for medical practices. The platform enables healthcare providers to operate more efficiently with artificial intelligence automation.

4 investors

AssistIQ uses AI-powered computer vision to automatically capture and recognize implants, tissue, and surgical supplies as they are used in the operating room, updating inventory and charge data without manual entry. It serves hospitals and health systems in the United States, integrating with EHR and ERP systems to improve billing accuracy, reduce waste, and support clinical documentation.

4 investors

Astrivax develops virus-targeted immunotherapies using its Launch-iT platform to eliminate cancer-causing viruses before they lead to disease, with an initial focus on HPV-driven cancers. The company targets an oncology therapeutic space for people at risk of virus-driven cancers.

4 investors

Atalanta develops RNA interference-based therapeutics aimed at treating central nervous system and neurological diseases. The company applies its founders' discoveries in RNAi to target diseases at their genetic source.

4 investors

Atara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease. The company focuses on next-generation cell-based therapies designed for patients worldwide.

4 investors

Atavistik Bio is a clinical-stage biotechnology company developing allosteric small-molecule therapeutics that selectively modulate disease-causing proteins. Its pipeline includes ATV-1601, an oral AKT1-selective inhibitor for Hereditary Hemorrhagic Telangiectasia, and a JAK2V617F mutant-selective inhibitor for myeloproliferative neoplasms.

4 investors

Atlas Health uses AI-driven patient assistance to help health systems connect patients to financial resources and reduce barriers to care. The platform simplifies healthcare funding complexity to improve access and patient outcomes.

4 investors

Attane Health provides nutritious groceries and educational resources tailored for people with chronic health conditions. The company combines food access with personalized support to help individuals manage their health through dietary intervention.

4 investors

Auransa is a clinical-stage, AI-native biopharma company that analyzes large human disease datasets to discover and develop novel cancer therapies. It works collaboratively with pharmaceutical companies and academic institutions to advance its drug discovery programs.

4 investors